Cyclooxygenase-2 Functions as a Downstream Mediator of Lysophosphatidic Acid to Promote Aggressive Behavior in Ovarian Carcinoma Cells

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1970 • 253,849 citations

Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes.

1987 • 5,066 citations

Cyclooxygenase in biology and disease

1998 • 2,483 citations

Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates

1980 • 1,991 citations

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

1996 • 1,473 citations

Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice

1997 • 1,417 citations

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1997 • 1,411 citations

The emerging role of lysophosphatidic acid in cancer

2003 • 1,086 citations

Signal characteristics of G protein-transactivated EGF receptor

1997 • 669 citations

Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers

1998 • 642 citations

Growth factor-like action of phosphatidic acid

1986 • 531 citations

COX‐2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX‐2 inhibitor celecoxib

2001 • 490 citations

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

2001 • 463 citations

Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer

2002 • 461 citations

Cyclooxygenase-2: a novel target for cancer chemotherapy?

2001 • 423 citations

Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.

1999 • 405 citations

Cyclooxygenase-2 is overexpressed in human cervical cancer.

2001 • 330 citations

Lysophospholipids Are Potential Biomarkers of Ovarian Cancer

2004 • 329 citations

Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.

1995 • 325 citations

Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells

1997 • 317 citations

Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2

2004 • 297 citations

NSAIDs inhibit αVβ3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis

2001 • 280 citations

Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer

2003 • 276 citations

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

2002 • 271 citations

Lysophosphatidic Acid Induction of Vascular Endothelial Growth Factor Expression in Human Ovarian Cancer Cells

2001 • 245 citations

Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer

2000 • 243 citations

Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.

2001 • 241 citations

Electrospray Ionization Mass Spectrometry Analysis of Lysophospholipids in Human Ascitic Fluids: Comparison of the Lysophospholipid Contents in Malignant vs Nonmalignant Ascitic Fluids

2001 • 234 citations

Regulation of Cyclooxygenase-2 pathway by HER2 receptor

1999 • 226 citations

Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.

2002 • 224 citations

Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.

2001 • 200 citations

Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors

2000 • 194 citations

Expression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian Carcinoma

2002 • 190 citations

Malignant effusions contain lysophosphatidic acid (LPA)-like activity

1998 • 178 citations

K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1.

2001 • 168 citations

Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study

2001 • 163 citations

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients

2002 • 157 citations

Prostaglandin E2 Promotes Integrin αVβ3-dependent Endothelial Cell Adhesion, Rac-activation, and Spreading through cAMP/PKA-dependent Signaling

2002 • 156 citations

Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells

2003 • 154 citations

Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.

1999 • 147 citations

Epidermal Growth Factor Receptor Signaling and the Invasive Phenotype of Ovarian Carcinoma Cells

2001 • 144 citations

Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

2001 • 137 citations

Ovulation as a Tissue Remodelling Process

1995 • 122 citations

PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells

2003 • 120 citations

Lysophospholipids Increase Interleukin-8 Expression in Ovarian Cancer Cells

2001 • 116 citations

Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents.

2002 • 110 citations

Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398

2000 • 99 citations

Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference

2003 • 98 citations

Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho.

2002 • 98 citations

Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian Cancer

2002 • 98 citations

Aspirin and Epithelial Ovarian Cancer

2001 • 95 citations

Critical Role of Lysophospholipids in the Pathophysiology, Diagnosis, and Management of Ovarian Cancer

2002 • 89 citations

The MEK/ERK pathway mediates COX‐2‐selective NSAID‐induced apoptosis and induced COX‐2 protein expression in colorectal carcinoma cells

2002 • 88 citations

Inhibition of Ovulation in the Perfused Rat Ovary by the Synthetic Collagenase Inhibitor SC 444631

1991 • 87 citations

The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases

2003 • 83 citations

An Epidermal Growth Factor Receptor/Gab1 Signaling Pathway Is Required for Activation of Phosphoinositide 3-Kinase by Lysophosphatidic Acid

1999 • 81 citations

Aspirin and ovarian cancer: An Italian case-control study

2000 • 77 citations

The effect of cyclooxygenase‐2 expression on tumor vascularity in advanced stage ovarian serous carcinoma

2003 • 76 citations

Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies

2003 • 74 citations

Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins

1998 • 71 citations

Non‐steroidal anti‐inflammatory drugs inhibit matrix metalloproteinase‐2 expression via repression of transcription in lung cancer cells

2001 • 70 citations

Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium

2003 • 69 citations

Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms

2001 • 56 citations

Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells

2000 • 54 citations

Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells

2003 • 53 citations

Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies

2003 • 52 citations

The Scientific Basis of Early Detection of Epithelial Ovarian Cancer: The National Ovarian Cancer Early Detection Program (Nocedp)

2002 • 51 citations

Reproductive consequences of COX-2 inhibition

2001 • 45 citations

Cooperative effects of matrix metalloproteinase and cyclooxygenase-2 inhibition on intestinal adenoma reduction

2003 • 33 citations

A Mechanism for Cox-2 Inhibitor Anti-Inflammatory Activity in Chemoprevention of Epithelial Cancers

2004 • 28 citations

Epidermal growth factor receptor (EGFR) antisense transfection reduces the expression of EGFR and suppresses the malignant phenotype of a human ovarian cancer cell line.

1998 • 23 citations

Characterization of epidermal growth factor receptor function in Lysophosphatidic acid signaling in PC12 cells

2000 • 17 citations